Whole-body hyperthermia: technical details
A deeper look at the equipment, protocols, temperature monitoring, and the physiological science behind therapeutic whole-body hyperthermia for Lyme disease.
Read more →Reviewed by Julian Douwes M.D., Chief Medical Officer, Klinik St. Georg
Whole-body hyperthermia is the cornerstone of advanced Lyme disease treatment in Germany. By raising core body temperature to a precise therapeutic range, this procedure targets the documented temperature sensitivity of Borrelia bacteria—the organisms responsible for Lyme disease. Over three decades and more than 30,000 treatment sessions, it has become the most refined non-antibiotic approach to persistent Lyme disease available today.
What it is: A controlled medical procedure that raises core body temperature to 41.6–41.8°C under sedation to target the heat sensitivity of Borrelia bacteria.
How it works: At these temperatures, Borrelia burgdorferi and related species become structurally unstable (thermolability), documented in laboratory research by Reisinger et al. The procedure also activates immune function and enhances antimicrobial effectiveness.
Who it is for: Patients with persistent Lyme disease symptoms who have not responded adequately to conventional antibiotic treatment, and who meet medical eligibility criteria.
Clinical experience: More than 30,000 hyperthermia sessions have been performed at St. George Hospital since the early 1990s, treating over 12,000 Lyme disease patients from more than 90 countries.
The scientific basis for hyperthermia treatment rests on a well-documented biological property: Borrelia burgdorferi sensu lato—the group of spirochetal bacteria that cause Lyme disease—are thermolabile. This means they become structurally unstable and lose viability when exposed to temperatures above their normal survival range.
Laboratory research, including work by Reisinger et al., has demonstrated that Borrelia bacteria begin to lose structural integrity at temperatures above 41°C. At 41.6–41.8°C, these organisms cannot maintain the cellular structures necessary for survival and reproduction. This temperature sensitivity is not unique to Borrelia—many spirochetal organisms share this property—but it is particularly well-characterized in the Lyme disease context.
Whole-body hyperthermia works through three complementary mechanisms:
The precise core body temperature range at which Borrelia bacteria become structurally unstable. This target is maintained for approximately two hours during the treatment session, with continuous monitoring ensuring safety and therapeutic accuracy.
Lyme disease is a systemic infection. Borrelia bacteria disseminate throughout the body, colonizing joints, connective tissue, the nervous system, and other organ systems. Localized heat treatments—infrared saunas, local hyperthermia devices, or hot baths—raise skin and superficial tissue temperatures but cannot reliably elevate core body temperature to the therapeutic range needed to affect bacteria in deep tissue.
Whole-body hyperthermia, as performed in a hospital setting, raises the actual core temperature of the body. This is not a wellness procedure. It is a medical intervention that requires anesthesia, continuous vital sign monitoring, and clinical expertise developed over thousands of treatments.
Hyperthermia is not a standalone treatment. It is the central element of a comprehensive, multimodal treatment program that typically spans two to three weeks. Understanding the full process helps you prepare for what to expect—physically, logistically, and emotionally.
Your treatment begins with an extensive diagnostic workup that goes well beyond standard Lyme testing. This includes advanced serological panels, co-infection screening (Babesia, Bartonella, Ehrlichia, Rickettsia, and others), immune function assessment, inflammatory markers, organ function panels, and cardiac evaluation. The results determine your specific treatment protocol and confirm medical eligibility for hyperthermia.
Before the hyperthermia session, you receive preparatory treatments designed to optimize your body's ability to respond. This may include IV antimicrobials, immune modulation, detoxification support, and nutritional optimization. The medical team reviews your diagnostic results, explains the treatment plan, and addresses your questions. An anesthesiology consultation confirms your fitness for sedation.
On the day of the procedure, you are placed under deep sedation using propofol-based anesthesia. Core body temperature is then gradually raised to the target range of 41.6–41.8°C using a controlled infrared heating system. The target temperature is maintained for approximately two hours. Throughout the entire procedure—which lasts six to eight hours including warm-up and cool-down phases—a medical team continuously monitors heart rate, blood pressure, oxygen saturation, core temperature, ECG, and other vital parameters. IV antibiotics and supportive medications are administered during the session for maximum synergistic effect.
The first 48–72 hours after hyperthermia are an intensive recovery period. You will feel fatigued, and many patients experience flu-like symptoms, body aches, and general malaise. This is expected. Your medical team monitors you closely and provides IV fluids, detoxification support, and symptomatic care. Most patients begin to feel noticeably better within three to five days after the session.
The treatment program continues with additional therapies tailored to your specific needs. These may include further antimicrobial courses, IV laser therapy, H.E.L.P. apheresis (blood filtration), ozone therapy, immune support, and nutritional rehabilitation. A second hyperthermia session may be scheduled if clinically indicated. Before discharge, your medical team provides a detailed follow-up plan and coordinates with your home physicians.
Whole-body hyperthermia is a significant medical procedure. It is not appropriate for every Lyme disease patient, and responsible medical practice requires thorough evaluation before treatment. Eligibility is determined during a consultation and confirmed by diagnostic results after you arrive at the hospital.
These lists are not exhaustive. Many patients fall into gray areas that require individual clinical judgment. Conditions that might seem disqualifying are sometimes manageable with appropriate precautions. The consultation process exists precisely to evaluate your individual case.
If you are unsure whether you are eligible, the best first step is to request a case review. Our medical team will assess your medical history and advise you before you make any travel commitments.
We believe that honest communication about risks is essential to informed consent and genuine trust. Whole-body hyperthermia is a real medical procedure with real risks. It is not a casual wellness treatment. Here is what you should know.
The hyperthermia session is conducted with the same level of monitoring you would expect in an operating room. A dedicated anesthesiologist and nursing team are present throughout. Continuous monitoring includes:
This level of monitoring allows the medical team to respond immediately to any deviation from expected parameters. The temperature elevation is controlled precisely—it is raised gradually and can be stopped or reversed at any point if needed.
The following side effects are common and expected after hyperthermia. They are not signs that something went wrong—they are part of the body's response to the treatment:
As with any procedure involving general anesthesia and significant physiological stress, serious adverse events are possible. These are rare in the context of over 30,000 sessions performed, but you should be aware of them:
The pre-treatment diagnostic workup and anesthesiology consultation exist specifically to identify patients at elevated risk and to make treatment safer for those who proceed. This is why we insist on comprehensive evaluation before treatment—not as a formality, but as a genuine safety measure.
Hyperthermia sessions performed at St. George Hospital since the early 1990s. This volume of clinical experience is one of the largest in the world for Lyme-specific hyperthermia, and it informs the safety protocols, monitoring standards, and clinical judgment applied to every patient.
Honest outcome reporting is more important to us than optimistic marketing. Here is what clinical experience across more than 12,000 Lyme patients has shown:
Through decades of clinical observation, several factors have been identified that appear to influence treatment response:
Most patients do not feel better immediately after hyperthermia. In fact, the first few days typically involve feeling worse (Herxheimer reaction and post-procedure recovery). Meaningful improvement usually becomes apparent 4 to 12 weeks after treatment, with continued gradual improvement over 6 to 12 months. This timeline requires patience—and it is important to set that expectation honestly before treatment begins.
"I did not feel better right away. The first week after treatment was one of the hardest of my life. But at about the six-week mark, I realized I was doing things I had not been able to do in years. By three months, the difference was undeniable. It was not instant, and it was not easy—but it was real."
Michael R., United Kingdom — Treated 2025
Individual experience. Results vary between patients. Testimonials are not guarantees of outcome.
Antibiotics remain the standard first-line treatment for Lyme disease, and for many patients, they are effective. Hyperthermia is not a replacement for antibiotics in early Lyme disease. It is a complementary and alternative approach for patients whose disease has persisted despite antibiotic treatment, or for whom further antibiotic courses are not viable or have not produced results.
| Factor | Antibiotic treatment | Whole-body hyperthermia |
|---|---|---|
| Mechanism | Kills or inhibits bacterial growth through biochemical action | Exploits thermal vulnerability of Borrelia; activates immune response; enhances antimicrobial penetration |
| Effective against persisters | Limited effectiveness against metabolically dormant forms of Borrelia | Heat-based mechanism is independent of bacterial metabolic state |
| Tissue penetration | Varies by antibiotic; some poorly penetrate CNS, joints, biofilms | Whole-body temperature elevation reaches all tissues systemically |
| Treatment duration | Weeks to months of daily oral or IV administration | Single session (6–8 hours) within a 2–3 week treatment program |
| Side effects | GI disruption, antibiotic resistance risk, hepatotoxicity, microbiome damage | Post-procedure fatigue, Herxheimer reaction, anesthesia-related risks |
| Setting | Outpatient (oral) or hospital (IV) | Hospital-based with anesthesia and continuous monitoring |
| Evidence base | Established standard of care with extensive clinical trial data | Laboratory evidence of thermolability; institutional clinical experience over 30,000 sessions; limited controlled trial data |
An important distinction: in practice, these approaches are not mutually exclusive. The hyperthermia treatment protocol at St. George Hospital includes concurrent antibiotic administration, combining thermal and pharmacological mechanisms for a synergistic effect. The question is not "either/or" but rather "when is hyperthermia the appropriate next step?"
For a more detailed comparison, see our full guide: Hyperthermia vs. antibiotics for Lyme disease.
A case review is a no-commitment first step. Submit your medical history and symptoms, and our medical team will evaluate whether hyperthermia-based treatment is appropriate for your situation.
A deeper look at the equipment, protocols, temperature monitoring, and the physiological science behind therapeutic whole-body hyperthermia for Lyme disease.
Read more →A detailed walkthrough of what to expect during a 2–3 week treatment program at St. George Hospital, from arrival to discharge.
Read more →Comprehensive information about hyperthermia safety, contraindications, monitoring protocols, and how risk is managed before, during, and after treatment.
Read more →